Qanatpharma AG
Biotechnology · Stans, Nidwalden
Qanatpharma AG is a Swiss biotechnology company based in Stans, Canton of Nidwalden, listed in the Swiss commercial register since 2020 (UID CHE-336.262.668).
Board members & signatories
- Christian Albrecht — Präsident des Verwaltungsrates
- Caspar Jucho — Mitglied des Verwaltungsrates
- Nicolas Albrecht — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt den Erwerb, die Entwicklung und die Verwertung von immateriellen Rechten an, sowie den Verkauf und Vertrieb von, Pharmazeutika, Medizinprodukten, therapeutischen und diagnostischen Verfahren sowie sonstigen Produkten und Dienstleistungen im Bereich Healthcare. Die Gesellschaft kann im In- und Ausland Zweigniederlassungen und Tochtergesellschaften errichten sowie Beteiligu…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Qanatpharma does
OFFERING
Qanatpharma AG focuses on developing therapies targeting resistance artery dysfunction, which is linked to various cardiovascular diseases. Their key programs include LYRIC-HF, which aims to address cognitive impairment in heart failure patients, and the GENESiS program, which is dedicated to creating small molecule and biologic solutions for heart failure and subarachnoid hemorrhage.
Unlock the full analysis →Similar companies
- Topadur Pharma AG — Pharmaceuticals · Schlieren
- Novartis International AG — Pharmaceuticals · Basel
- ADC Therapeutics AG — Biotechnology · Epalinges
- AL-S Pharma AG — Pharmaceuticals · Schlieren
- Partex.AI Therapeutics AG — Pharmaceuticals · Cham
- Novartis Innovative Therapies AG — Pharmaceuticals · Fribourg
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime